Do single-arm trials have a role in drug development plans incorporating randomised trials?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Do single-arm trials have a role in drug development plans incorporating randomised trials?
Authors
Keywords
-
Journal
PHARMACEUTICAL STATISTICS
Volume 15, Issue 2, Pages 143-151
Publisher
Wiley
Online
2015-11-26
DOI
10.1002/pst.1726
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of Single-Arm vs. Randomized Phase II Clinical Trials: A Bayesian Approach
- (2014) Valeria Sambucini Journal of Biopharmaceutical Statistics
- Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer
- (2014) Raghunadharao Digumarti et al. LUNG CANCER
- A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials
- (2014) J. Bowden et al. PHARMACEUTICAL STATISTICS
- Predicting success: Optimizing phase II ALS trials for the transition to phase III
- (2014) James D. Berry et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Use of historical control data for assessing treatment effects in clinical trials
- (2013) Kert Viele et al. PHARMACEUTICAL STATISTICS
- Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials
- (2011) Gregory R Pond et al. Clinical Trials
- More Randomization in Phase II Trials: Necessary but not Sufficient
- (2011) L. Rubinstein et al. JNCI-Journal of the National Cancer Institute
- Randomized Phase II Trials: A Long-term Investment With Promising Returns
- (2011) M. R. Sharma et al. JNCI-Journal of the National Cancer Institute
- The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
- (2010) L. Seymour et al. CLINICAL CANCER RESEARCH
- Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trials
- (2010) A.P. Mander et al. Contemporary Clinical Trials
- Randomized Phase II Trials: Inevitable or Inadvisable?
- (2010) Hui K. Gan et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trials: Misleading and Unreliable
- (2010) David J. Stewart JOURNAL OF CLINICAL ONCOLOGY
- Comparison of Error Rates in Single-Arm Versus Randomized Phase II Cancer Clinical Trials
- (2010) Hui Tang et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Designs
- (2009) L. Rubinstein et al. CLINICAL CANCER RESEARCH
- Optimising the design of phase II oncology trials: The importance of randomisation
- (2008) Mark J. Ratain et al. EUROPEAN JOURNAL OF CANCER
- Recommended changes to oncology clinical trial design: Revolution or evolution?
- (2007) Mark J. Ratain et al. EUROPEAN JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started